Klingemann H - Search Results

1

The NK-92 cell line-30 years later: its impact on natural killer cell research and treatment of cancer.

Klingemann H. Klingemann H. Cytotherapy. 2023 May;25(5):451-457. doi: 10.1016/j.jcyt.2022.12.003. Epub 2023 Jan 6. Cytotherapy. 2023. PMID: 36610812 Free article. Review.

2

CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation.

Eitler J, Rackwitz W, Wotschel N, Gudipati V, Murali Shankar N, Sidorenkova A, Huppa JB, Ortiz-Montero P, Opitz C, Künzel SR, Michen S, Temme A, Loureiro LR, Feldmann A, Bachmann M, Boissel L, Klingemann H, Wels WS, Tonn T. Eitler J, et al. Among authors: klingemann h. J Immunother Cancer. 2024 Feb 27;12(2):e008155. doi: 10.1136/jitc-2023-008155. J Immunother Cancer. 2024. PMID: 38417916 Free PMC article.

3

The confluence of legacy, corporate social responsibility, and public health: The case of Migros and alcohol-free retailing in Switzerland.

Klingemann H, Lesch M. Klingemann H, et al. Int J Drug Policy. 2024 Mar;125:104333. doi: 10.1016/j.drugpo.2024.104333. Epub 2024 Feb 12. Int J Drug Policy. 2024. PMID: 38350167 Free article.

4

Viscum album (mistletoe) extract for dogs with cancer?

Klingemann H. Klingemann H. Front Vet Sci. 2024 Jan 3;10:1285354. doi: 10.3389/fvets.2023.1285354. eCollection 2023. Front Vet Sci. 2024. PMID: 38234984 Free PMC article. Review.

5

CCR7 expression in CD19 chimeric antigen receptor-engineered natural killer cells improves migration toward CCL19-expressing lymphoma cells and increases tumor control in mice with human lymphoma.

Schomer NT, Jiang ZK, Lloyd MI, Klingemann H, Boissel L. Schomer NT, et al. Among authors: klingemann h. Cytotherapy. 2022 Aug;24(8):827-834. doi: 10.1016/j.jcyt.2022.02.006. Epub 2022 Apr 8. Cytotherapy. 2022. PMID: 35400595

6

Immunotherapy for Dogs: Still Running Behind Humans.

Klingemann H. Klingemann H. Front Immunol. 2021 Aug 5;12:665784. doi: 10.3389/fimmu.2021.665784. eCollection 2021. Front Immunol. 2021. PMID: 34421888 Free PMC article. Review.

7

Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting.

Eitler J, Wotschel N, Miller N, Boissel L, Klingemann HG, Wels W, Tonn T. Eitler J, et al. Among authors: klingemann hg. J Immunother Cancer. 2021 Jan;9(1):e001334. doi: 10.1136/jitc-2020-001334. J Immunother Cancer. 2021. PMID: 33468562 Free PMC article.

8

Successes and failures in treatment of substance abuse: Treatment system perspectives and lessons from the European continent.

Klingemann H. Klingemann H. Nordisk Alkohol Nark. 2020 Aug;37(4):323-337. doi: 10.1177/1455072520941977. Epub 2020 Aug 17. Nordisk Alkohol Nark. 2020. PMID: 35310921 Free PMC article.

9

Design and Content Quality of Alcohol-Related German, French and Italian Self-Tracking Applications.

Klingemann H, Flückiger M, Bongard T, Büchi M, Carrara M. Klingemann H, et al. Subst Use Misuse. 2020;55(5):851-859. doi: 10.1080/10826084.2019.1708117. Epub 2020 Jan 14. Subst Use Misuse. 2020. PMID: 31934803

10

Cellular Immunotherapy of Canine Cancer.

Addissie S, Klingemann H. Addissie S, et al. Among authors: klingemann h. Vet Sci. 2018 Dec 6;5(4):100. doi: 10.3390/vetsci5040100. Vet Sci. 2018. PMID: 30563208 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

229 results

Search Page